JP Morgan Cazenove Analyst Recommendations & Stock PicksView the latest stock recommendations issued by analysts at JP Morgan Cazenove. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from JP Morgan Cazenove's equity research team. MarketBeat is not affiliated with or endorsed by JP Morgan Cazenove.Updated 7/7/2025 Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings1 Last 12 MonthsBuy Ratings0 Last 12 MonthsSell Ratings0 Last 12 MonthsCompanies Covered1 Last 12 Months Country All Countries USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Full History Latest Per Company Show All Ratings Strong Buy Buy Hold Sell Rating All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Price Target Change Action Any Change Raised 5%+ Raised 10%+ Raised 20%+ Lowered 5%+ Lowered 10%+ Lowered 20%+ Price Target Change Export CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsTSNTyson Foods$66.490.0%7/7/2025 Lower Price Target$61.00 ➝ $60.00Neutral00.00%View details for JP Morgan Cazenove rating of Tyson Foods (NYSE:TSN) on 7/7/2025LPSNLivePerson$2.13+2.9%2/25/2022 Downgrade$900.00 ➝ $315.00Overweight ➝ Neutral00.00%View details for JP Morgan Cazenove rating of LivePerson (NASDAQ:LPSN) on 2/25/2022KBCSYKBC Group€64.41+0.2%10/6/2021Raul SinhaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost Price Target€79.00 ➝ €85.00Overweight00.00%View details for JP Morgan Cazenove rating of KBC Group (OTCMKTS:KBCSY) on 10/6/2021NFLXNetflix$90.12+2.3%9/8/2021Doug AnmuthSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost Price Target$62.50 ➝ $70.50Overweight00.00%View details for JP Morgan Cazenove rating of Netflix (NASDAQ:NFLX) on 9/8/2021BCSBarclays$23.81-0.3%6/16/2021Kian AbouhosseinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeOverweight00.00%View details for JP Morgan Cazenove rating of Barclays (NYSE:BCS) on 6/16/2021SCGLYSociete Generale Group$15.85-1.9%6/16/2021Kian AbouhosseinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeOverweight00.00%View details for JP Morgan Cazenove rating of Societe Generale Group (OTCMKTS:SCGLY) on 6/16/2021NYTNew York Times$74.34+0.0%4/30/2018 Reiterated RatingOverweight00.00%View details for JP Morgan Cazenove rating of New York Times (NYSE:NYT) on 4/30/2018IRWDIronwood Pharmaceuticals$3.76-4.0%4/28/2016 Reiterated Rating$15.00Overweight00.00%View details for JP Morgan Cazenove rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 4/28/2016SANBanco Santander$12.16-1.8%4/25/2016 UpgradeNeutral ➝ Overweight00.00%View details for JP Morgan Cazenove rating of Banco Santander (NYSE:SAN) on 4/25/2016JPMJPMorgan Chase & Co.$301.910.0%2/24/2016 Lower Price Target$71.00 ➝ $67.00Outperform ➝ Buy00.00%View details for JP Morgan Cazenove rating of JPMorgan Chase & Co. (NYSE:JPM) on 2/24/2016AMAntero Midstream$21.99-0.4%2/5/2016 Reiterated Rating$19.00 ➝ $25.00Underweight00.00%View details for JP Morgan Cazenove rating of Antero Midstream (NYSE:AM) on 2/5/2016JPMJPMorgan Chase & Co.$301.910.0%2/5/2016 DowngradeBuy ➝ Neutral00.00%View details for JP Morgan Cazenove rating of JPMorgan Chase & Co. (NYSE:JPM) on 2/5/2016TROWT. Rowe Price Group$100.89-0.9%1/15/2016 Reiterated Rating$74.00 ➝ $68.00Underweight00.00%View details for JP Morgan Cazenove rating of T. Rowe Price Group (NASDAQ:TROW) on 1/15/2016LYGLloyds Banking Group$5.38-1.0%12/3/2015 Reiterated RatingBuy00.00%View details for JP Morgan Cazenove rating of Lloyds Banking Group (NYSE:LYG) on 12/3/2015BCSBarclays$23.81-0.3%11/25/2015 Reiterated RatingBuy00.00%View details for JP Morgan Cazenove rating of Barclays (NYSE:BCS) on 11/25/2015GSKGSKGBX 1,910.38+0.6%11/17/2015 Reiterated RatingGBX 1,370Neutral00.00%View details for JP Morgan Cazenove rating of GSK (LON:GSK) on 11/17/2015 MarketBeat Community Rating for JP Morgan CazenoveMarketBeat's community ratings are surveys of what our community members think about JP Morgan Cazenove and other research firms in the last 90 days. Vote "Outperform" if you believe JP Morgan Cazenove's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe JP Morgan Cazenove's recommendations will underperform the broader market over the long term. You may vote once every thirty days. Log in to vote on this brokerage. COMMUNITY RATINGS2.6out of 5 (last 90 days)2.6 of 5 stars OUTPERFORM VOTES 32 Believe will outperform the market UNDERPERFORM VOTES 29 Believe will underperform the market JP Morgan Cazenove Stock Coverage by SectorJP Morgan Cazenove concentrates its research most heavily in Consumer Staples (100.0%). The chart below shows how JP Morgan Cazenove's 1 rated company is distributed across all 1 sector it covers.Consumer Staples1 company100.0%Best & Worst CallsBest Call000.0%NYSE:JPMLower Price Target • Feb 24, 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NASDAQ:NFLXBoost Price Target • Sep 8, 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI. JP Morgan Cazenove - Frequently Asked Questions What sectors does JP Morgan Cazenove specialize in? JP Morgan Cazenove has the deepest coverage in Consumer Staples (100.0% of rated companies). How often does JP Morgan Cazenove change its stock ratings? JP Morgan Cazenove issued 1 ratings over the last 12 months across 1 companies — an average of roughly 0 rating actions per month. These include lower price target. MarketBeat tracks every rating change as it's published so you can see the most current JP Morgan Cazenove analyst actions. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupMorgan StanleyRoyal Bank Of CanadaJefferies Financial GroupThe Goldman Sachs GroupStifel NicolausRaymond James FinancialMizuhoBank of AmericaKeyCorpSanford C. BernsteinWolfe ResearchCICC Research Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
